期刊文献+

TNF-α-NF-κB对成骨细胞分化过程中BMP-2-Smad1信号通路的影响 被引量:5

The effects of TNF-α and NF-κB on BMP-2-Smad1 signaling pathway during osteoblast differentiation
下载PDF
导出
摘要 目的探讨肿瘤坏死因子-α(TNF-α)-NF-κB信号通路通过骨形态发生蛋白-2(BMP-2)-Smad1信号通路对成骨细胞分化影响的分子机制。方法应用BMP-2体外诱导鼠肌源细胞C2C12向成骨细胞分化模型,瞬时转染表达其下游效应物,通过实时RT-PCR以及蛋白电泳和免疫印迹技术(Western-blot),检测其下游效应物Smad1与核转录因子(NF-kB)及其抑制剂(IκBα),研究TNF-α和NF-κB对BMP-2-Smad1信号通路的影响。结果 TNF-α能够将Smad1(BMP-2的下游效应物)的活性从对照组的2.04倍降低至0.63倍。NF-κB过表达则将Smad1活性从2.04倍降低至0.39倍。蛋白质印迹实验可见,TNF-α能明显降低BMP2活化的C2C12细胞中磷酸化Smad1的含量,而RT-PCR研究发现其并不能改变Smad1的mRNA丰度。结论 TNF-α抑制成骨细胞分化其分子机制是通过TNF-α激活NF-kB而降低BMP-2信号通路中磷酸化的Smad1,进而抑制BMP-2-Smad1通路活性而发挥作用。提示持续性的炎症反应能直接抑制成骨细胞的分化和骨形成。 Objective To investigate the molecular mechanisms of the effects of TNF-α and NF-κB on BMP-2-Smadl signaling pathways during osteoblast differentiation. Methods Mouse myoblast C2C12 cells treated with BMP-2 were used as model of osteoblast differentiation. Transient transfection was performed to express the downstream effeetors. Luciferase reporter activity assay and RT-PCR were performed to measure the expressions of NF-κB and its inhibitor IκBα, for studying the effect of TNF-α and NF-κB on BMP-2- Smadl signaling pathway. Results TNF-α decreased the activity of its downstream molecule Smadl from 2.04 times in the control to 0. 63 times. Overexpression of NF-κB decreased the activity of Smadl from 2.04 times to 0. 39 times. Western blotting data showed that TNF-α significantly reduced the expression of phospho-Smadl induced by BMP2 in C2C12 cells. However, RT-PCR data indicated that TNF-α did not change the mRNA expression of Smadl. Conclusion TNF-α inhibited osteoblast differentiation through the activation of NF-κB by TNF-α, causing a decrease of phosphorylated Smadl in BMP-2 signaling pathway which further inhibited the BMP-2-Smadl signaling pathway. This suggested that persistent inflammation could directly inhibit osteoblast differentiation and bone formation.
出处 《中国骨质疏松杂志》 CAS CSCD 2011年第1期1-4,14,共5页 Chinese Journal of Osteoporosis
基金 国家自然科学基金面上项目(30672133)
  • 相关文献

参考文献12

  • 1Tsialogiannis E,Polyzois I,Oak Tang Q,et al.Targeting bone morphogenetic protein antagonists:in vitro and in vivo evidence of their role in bone metabolism.Expert Opin Ther Targets,2009,13:123-137.
  • 2Canalis E,Eeonomides AN,Gazzerro E.Bone morphogenetic proteins,their antagonists,and the skeleton.Endocr Bey,2003,24:218-235.
  • 3Xiao YT,Xiang LX,Shao JZ.Bone morphogenetic protein.Biochem Biophys Res Commun,2007,362:550-553.
  • 4Smith DM,Cooper GM,Mooney MP,et al.Bone morphogenetic protein 2 therapy for craniofaeial surgery.J Craniofac Surg,2008,19:1244-1259.
  • 5Rihn JA,Gates C,Glassman SD,et al.The use of bone morphogenetic protein in lumbar spine surgery.J Bone Joint Surg Am,2008,90:2014-2025.
  • 6Nohe A,Keating E,Knaus P,et al.Signal transduction of bone morphogenetie protein receptors.Cell Signal,2004,16:291-299.
  • 7Cao X,Chen D.The BMP signaling and in vivo bone formation.Gene,2005,357:1-8.
  • 8Ghosh S,Hayden MS.New regulators of NF-kappaB in inflammation.Nat Rev Immunol,2008,8:837-848.
  • 9Pande V,Ramos MJ.NF-kappaB in human disease:current inhibitors and prospects for de novo structure based design of inhibitors.Curr Med Chem,2005,12:357-374.
  • 10赵贤,李世昌,李小英.骨形成因子及其信号传导通路述评[J].中国骨质疏松杂志,2008,14(9):680-684. 被引量:9

二级参考文献28

  • 1童安莉,陈璐璐,丁桂芝.成骨细胞骨形成机制研究进展[J].中国骨质疏松杂志,1999,5(3):60-64. 被引量:31
  • 2任艳玲,郑洪新,杜松,赵金茹,李淑玲.TGF-β1及其信号转导蛋白Smad23在去卵巢大鼠骨组织中的表达及意义[J].中国骨质疏松杂志,2005,11(3):298-301. 被引量:17
  • 3Wei Liu, Shunqing Wang, Wei S, et al. Receptor activator of NF2 kappaB (RANK) cytoplasmic motif, 369PFQEP373, plays a predominant role in osteoclast survival in part by activating AktPPKB and its downstream effector AFX/FOXO4. J Biol Chem, 2005, 280 (52) : 43064-43072.
  • 4Lee SE, Woo KM, Kim SY, et al. The phosphatidylinositol 3- kinase, p38, and extracellular signal-regulated kinase pathways are involved in ostroclast differentiation. Bone, 2002, 30(1): 71-77.
  • 5郑庆云.纵跳对生长期大鼠骨密度、骨代谢生化指标及股骨BMP-2的影响.上海:华东师范大学出版社,2007.
  • 6Lieberman IH, Dudeney S, Reinhardt MK, et al. Initial outcome and efficacy of kyphoplasty in the treatment of painful osteoparotic vertebral compression fractures. Spine,2001, 26(14) : 1631-1638.
  • 7Mizuno A, Amizuka N, IrieK, et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun, 1998, 247(3): 610-615.
  • 8Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegefin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev, 1998,12(9) : 1260-1268.
  • 9Eghbali-Fatourechi G, Khosla S, Sanyal A, et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest,2003,111(8) : 1221-1230.
  • 10Xue Y, Karaplis AC, Hendy GN, et al. Genetic models show that parathyroid hormone and 1,25-(OH)2 D3 play distinct and synergistic roles in postnatal mineralion homeostasis and skeletal development. Hum Mol Genet, 2005, 14(11) : 1515-1528.

共引文献8

同被引文献71

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部